Inhalator
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
FIG. 1 is a bottom, right perspective view of an inhalator showing our new design;
FIG. 2 is a top plan view thereof;
FIG. 3 is a front elevational view thereof;
FIG. 4 is a rear elevational view thereof;
FIG. 5 is a left side elevational view thereof, the right side elevational view being a mirror image thereof;
FIG. 6 is a bottom plan view thereof;
FIG. 7 is a bottom, right perspective view of a second embodiment of FIG. 1;
FIG. 8 is a top plan view thereof;
FIG. 9 is a front elevational view thereof;
FIG. 10 is a rear elevational view thereof;
FIG. 11 is a left side elevational view thereof, the right side elevational view being a mirror image thereof;
FIG. 12 is a bottom plan view thereof;
FIG. 13 is a bottom, right perspective view of a third embodiment of FIG. 1;
FIG. 14 is a top plan view thereof;
FIG. 15 is a front elevational view thereof;
FIG. 16 is a rear elevational view thereof;
FIG. 17 is a left side elevational view thereof, the right side elevational view being a mirror image thereof; and
FIG. 18 is a bottom plan view thereof.
Type: Grant
Filed: Aug 13, 1987
Date of Patent: Oct 16, 1990
Assignee: Glaxo Group Limited (London)
Inventors: Norman A. Long (Hayling Island), Karl A. Garrill (Hertford)
Primary Examiner: A. Hugo Word
Assistant Examiner: Stella M. Reid
Law Firm: Darby & Darby
Application Number: 7/85,602